Plain-English translation of NCT05282095 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is tracking 300 young women in China who have been diagnosed with CIN2—early abnormal changes in cervical cells—to understand how HPV (human papillomavirus) integration status affects what happens next. Researchers will test your cervical cells and vaginal bacteria at five time points over 12 months to see whether these results can predict whether your condition will heal on its own, stay stable, or progress. The goal is to help doctors better predict outcomes and guide treatment decisions for young women with this condition.
Currently, doctors have limited ways to predict which women with early cervical cell changes will recover naturally and which might develop more serious problems. This study aims to discover whether tracking how the HPV virus integrates into cells—combined with information about your vaginal bacteria and cell appearance—can help doctors make more accurate predictions and potentially avoid unnecessary treatment in women who will heal on their own.
You will visit the study clinic at the time of enrollment and then at 3, 6, 9, and 12 months afterward. At each visit, doctors will perform a colposcopy (a magnified look at your cervix), take cell samples from your cervix, and collect samples to check your vaginal bacteria. During the 12-month period, you will not receive treatment unless your condition gets worse. The study is designed to carefully monitor your condition and gather information about how the virus and your body's bacteria affect what happens to your cervical cells over time.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China